| Literature DB >> 23584347 |
Peter E Clark1, Neeraj Agarwal, Matthew C Biagioli, Mario A Eisenberger, Richard E Greenberg, Harry W Herr, Brant A Inman, Deborah A Kuban, Timothy M Kuzel, Subodh M Lele, Jeff Michalski, Lance C Pagliaro, Sumanta K Pal, Anthony Patterson, Elizabeth R Plimack, Kamal S Pohar, Michael P Porter, Jerome P Richie, Wade J Sexton, William U Shipley, Eric J Small, Philippe E Spiess, Donald L Trump, Geoffrey Wile, Timothy G Wilson, Mary Dwyer, Maria Ho.
Abstract
Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.Entities:
Mesh：
Year: 2013 PMID： 23584347 DOI： 10.6004/jnccn.2013.0059
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908